Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	4.85	-394.96	-415.07
Graham Fair Price	0.00	0.42	0.42
PEG	inf	0.00	-6.08
Price/Book	2.49	0.55	0.53
Price/Cash Flow	-2.49	-39.82	-38.85
Prices/Earnings	2.49	29.65	28.93
Price/Sales	2.49	16.77	16.37
Price/FCF	-2.49	-39.82	-38.85
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	1.01	1.01
Operating Margin	0.00	0.35	0.35
ROA	0.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	0.00
ROIC	< 0.005	< 0.005	-4.75
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.20	0.07	185.80
Dividends QOQ	4.79	0.00	inf
EBIT QOQ	0.03	0.00	inf
EPS QOQ	-0.05	0.00	inf
FCF QOQ	-4.96	0.00	inf
Revenue QOQ	-0.17	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	1205.30	100.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.25	0.28	14.48
Quick Ratio	17.82	36.65	105.72
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	1.29	1.29	0.00
Cash	0.53	0.53	0.00
Capex	< 0.005	< 0.005	0.00
Free Cash Flow	-0.02	-0.02	0.00
Revenue	0.04	0.04	0.00
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	17.82	17.82	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	78.90	111.30	41.07
Naive Interpretation	Member

06 - Financial Health · Bad

Rating